fig2
![Antithrombotic therapy in patients undergoing transcatheter aortic valve replacement (TAVR): from current evidence to perspective](https://image.oaes.cc/69ea3d03-e552-420f-bcd8-bd72613a0133/5132.fig.2.jpg)
Figure 2. Central illustration: the best antithrombotic regimen in patients with or without indication to long-term oral anticoagulant therapy. OAC: Oral anticoagulant; SAPT: single antiplatelet therapy; DAPT: dual antiplatelet therapy; VKA: vitamin K antagonist; CV: cardiovascular; MI: myocardial infarction.